Pharmaceuticals: The Investment Opportunity in Obesity Treatment
A recent landmark study around weight-loss medicine could spark near-term growth opportunities in pharmaceuticals. ----- Transcript ----- Mark Purcell: Welcome to Thoughts on the Market. I'm Mark Purcell, Head of Morgan Stanley's European Pharmaceuticals Team. Terence Flynn: And I'm Terence Flynn, Head of the U.S.…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Thoughts on the Market →
Weight loss drugs: Scaling up
Here's How the New Weight Loss Drugs Could Change Everything
Money Talks: Why weight-loss drugs will reshape the world
The State of Weight-Loss Drugs
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.